Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/40219
標題: A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
作者: Yen, M.C.
林季千
Lin, C.C.
Chen, Y.L.
Huang, S.S.
Yang, H.J.
Chang, C.P.
Lei, H.Y.
Lai, M.D.
關鍵字: human dendritic cells;dna vaccine;tryptophan degradation;antitumor;immunity;ido expression;tumor-immunity;t-cells;inhibition;immunotherapy;tolerance
Project: Clinical Cancer Research
期刊/報告no:: Clinical Cancer Research, Volume 15, Issue 2, Page(s) 641-649.
摘要: 
Purpose: Indoleamine 2,3-dioxygenase (IDO), an enzyme that degrades tryptophan, is a negative immune regulatory molecule of dendritic cells. IDO-expressing dendritic cells suppress T cell responses and may be immunosuppressive in vivo. We hypothesized that silencing the IDO expression in skin dendritic cells in vivo could elicit antitumor activity in tumor-draining lymph nodes. Experimental Design: The efficiency of IDO-specific small interfering RNA (si RNA) was evaluated in vitro and in vivo. The therapeutic effect was evaluated in MBT-2 murine bladder tumor model and CT-26 colon tumor models. Results: IDO expression was down-regulated in CD11c-positive lymphocytes after IDO siRNA treatment. In vivo skin administration of IDO siRNA inhibited tumor growth and prolonged survival in both tumor models. The number of infiltrated T cells and neutrophils increased at tumor sites, which are correlated with therapeutic efficacy. The T cells may be mainly responsible for the immunologic rejection because the effect was abolished by depletion of CD8-positive T cells. Adoptive transfer of CD11c-positive dendritic cells from vaccinated mice delayed tumor progression. The cancer therapeutic effect was reproducibly observed with another IDO siRNA targeting at different site, suggesting the effect was not due to off-target effect. In a neu-overexpressing MBT-2 tumor model, IDO siRNA enhanced the therapeutic efficacy of Her2/Neu DNA vaccine. Down-regulation of IDO2, an IDO homologue, with siRNA also generated antitumor immunity in vivo. Conclusions: Antitumor immunity can be effectively elicited by physical delivery of siRNAs targeting immunoregulatory genes in skin dendritic cells in vivo, as shown by IDO and IDO2 in this report
URI: http://hdl.handle.net/11455/40219
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-08-1988
Appears in Collections:生物醫學研究所

Show full item record
 

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.